For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies researching your condition/s 21

Based on the information you provided, you may be eligible for the following studies researching your condition/s.

  • Phase III study of experimental drug LEE011 or placebo in combination w/tamoxifen/goserelin or NSAI/goserelin for TX of premenopausal women w/hormone receptor+, HER2-neg, advanced breast cancer. Study goal: learn whether LEE011 or placebo, when added to standard treatment (Tamoxifen + Goserelin or a non-steroidal aromatase inhibitor (NSAI) + Goserelin) helps reduce the growth of breast cancer cells in premenopausal women with hormone receptor positive, HER2-negative advanced breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • 18 years to 60 years
  • A Survey of Early Stage Breast Cancer Survivors: Oral Health Concerns and Challenges The purpose of our study is to see how breast cancer patients, survivors and women in general view their oral health as well as identifying specific oral health challenges they face. This study is researching all of the following topics: Breast cancer Dental Decay This study is looking for: female only women Volunteers with specific conditions
    • More than 25 years old
  • Neratinib for Patients with HER2 + Breast Cancer and Brain Metastases The purpose of this research study is to determine how well neratinib works in treating breast cancer that has spread to the brain. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Characterization of Circulating Tumor Cells from Subjects with Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index. The purpose of this experimental study is to determine the feasibility of investigating CTC and the expression of several biomarkers on/in the tumor cells that can be detected in blood of patients with breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • More than 18 years old
  • A Phase II Study of Neratinib in Metastatic HER2 Non-amplified but HER2 Mutant Breast Cancer The purpose of this research study is to test the cancer of women who have HER2┬┐negative to see if it has a HER2 mutation and, if so, see how the cancer responds to neratinib. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • Randomized, Open Label Study of MM-302 plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in Anthracycline Naive Patients with Locally Advanced/Metastatic HER2-Pos Breast Cancer Study purpose: see if MM-302 with trastuzumab can prevent cancer growth longer than other cancer drugs; find out if patients taking MM-302 combined with trastuzumab live longer, have fewer cancer symptoms, better quality of life, and fewer side effects than those receiving other cancer drugs This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Characteristics and Mechanisms of Cognitive Problems in Fibromyalgia Cognitive “fog" (slow and/or foggy thinking) is a very serious and common problem for people with different conditions such as fibromyalgia, depression, cancer, and multiple sclerosis. This study seeks to open a window onto the nature of cognitive fog in adults with these conditions. This study is researching all of the following topics: Breast cancer Depression Fibromyalgia Multiple sclerosis This study is looking for: male female both men and women Volunteers with specific conditions
    • 18 years to 60 years
  • Improving Adherence to Oral Cancer Agents and Self-Care of Symptoms Using an IVR The purpose of the study is to: (1) determine if daily reminders will help patients take their anti-cancer pills as prescribed and; (2) test strategies to manage symptoms between doctor office visits. We are hoping to learn better ways to support patients who are prescribed oral anti-cancer pills. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Melanoma Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 21 studies
Show more studies

Studies researching other conditions 72

You may also be eligible for the following studies researching other conditions, either as a volunteer with condition/s or as a healthy volunteer.